Egger H, Bartlett F, Itterly W, Rodebaugh R, Shimanskas C
Drug Metab Dispos. 1982 Jul-Aug;10(4):405-12.
The metabolism of aminoglutethimide was studied in the rat by use of the 14C-labeled compound. Following oral doses of 5 and 50 mg/kg, the drug was almost completely eliminated within 48 hr into urine and feces, mostly in the form of metabolites. In bile duct-cannulated rats, biliary excretion of radioactivity amounted to about 52% within 24 hr of an orally administered 50 mg/kg dose, with the remainder of the dose being eliminated into urine. The major urinary metabolites resulted from acetylation of the aniline moiety, hydroxylation of the glutarimide ring at positions 3 and 4, and oxidative elimination of the ethyl sidechain. The polar metabolites are accounted for by aromatic hydroxylation with subsequent sulfate conjugation and by a glutarimide ring-opened compound. In addition, a gamma-butyrolactone derivative was also identified.
利用14C标记的化合物在大鼠中研究了氨鲁米特的代谢。口服剂量为5和50mg/kg后,药物在48小时内几乎完全以代谢物的形式经尿液和粪便排出。在胆管插管的大鼠中,口服50mg/kg剂量后24小时内放射性胆汁排泄量约为52%,其余剂量经尿液排出。主要的尿液代谢物来自苯胺部分的乙酰化、戊二酰亚胺环在3位和4位的羟基化以及乙基侧链的氧化消除。极性代谢物是由芳香族羟基化随后与硫酸盐结合以及戊二酰亚胺开环化合物产生的。此外,还鉴定出一种γ-丁内酯衍生物。